Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis
1996

Measuring Carboplatin Levels in Melanoma Using Microdialysis

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): B Blochl-Daum, M Miller, V Meisinger, HG Eichler, A Fassolt, H Pehamberger

Primary Institution: Vienna University Hospital

Hypothesis

Microdialysis can effectively measure carboplatin concentration profiles in melanoma tumors.

Conclusion

Microdialysis is a valuable tool for measuring drug concentrations in solid tumors, providing insights into pharmacokinetics.

Supporting Evidence

  • Microdialysis allowed for the estimation of key pharmacokinetic parameters in the extracellular fluid of tumors.
  • Mean carboplatin concentrations in tumors were only 50-60% of serum levels.
  • Microdialysis was well tolerated by all patients with no adverse events reported.

Takeaway

This study shows that a special technique can help doctors see how much medicine gets into tumors, which is important for treating cancer.

Methodology

Microdialysis was used to sample carboplatin concentrations in serum, tumor, and subcutaneous tissue from six patients.

Limitations

The study's findings may not represent the entire tumor due to the placement of only one probe.

Participant Demographics

Six platinum-naive patients (4 female, 2 male) with a mean age of 58 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication